碘塞羅寧
(S)-2-Amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenyl)propanoic acid;3,3,5-Triiodo-L-thyronine;3,3',5'-Triiodo-L-thyronine;3,3’,5’-Triiodo-L-th;3,3’,5’-Triiodo-L-thyronine;3,3′,5′-Triiodo-L-thyronine;3,3′,5′-Triiodo-L-thyronine (Reverse T3) solution;3,3′,5′-Triiodo-L-thyronine 3,3′,5′-Triiodo-L-thyronine;L-Tyrosine,O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-;REVERSE T3;3',5',3-Triiodothyronine;Isoliothyronine;Reverse L-triiodothyronine;Reverse triiodothyronine;rT3;3,3',5'-Triiodothyronine;Triiodothyronine, reverse;Reverse Tri-Iodothyronine;Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-;L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-;8NZ4Y08T96;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenyl]propanoic acid;DSSTox_RID_82006;DSSTox_CID_26908;DSSTox_GSID_46908;O-(4-hy;3,3',5'-T3;LEVOTHYROXINE SODIUM IMPURITY K [EP IMPURITY];C07639;UNII-8NZ4Y08T96;SCHEMBL93385;BDBM50103763;C15H12I3NO4;AM83600;CAS-5817-39-0;Tox21_112797;HY-W010696;DTXCID1026908;4-(4-hydroxy-3,5-diiodophenoxy)-3-iodo-L-phenylalanine;CHEMBL1743304;AKOS016843979;DTXSID3046908;Alanine, 3-[4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenyl]-, L- (8CI);NCGC00344545-01;5817-39-0;3,3',5'-L-Triiodothyronine;Levothyroxine Impurity K;O-(4-hydroxy-3,5-diiodophenyl)-3-iodo-L-tyrosine;CHEBI:11684;Tox21_112797_1;3,3 inverted exclamation marka,5 inverted exclamation marka-Triiodo-L-thyronine;NCGC00181338-01;L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3-iodo- (9CI);3,3',5'-TRIIODOTHYRONINE, L-;Q60998609;F17354;ALANINE, 3-(4-(4-HYDROXY-3,5-DIIODOPHENOXY)-3-IODOPHENYL)-, L-;(2S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3-iodophenyl]propanoic Acid (3,3',5'-Triiodo-L-Thyronine);CS-W011412;REVERSETRIIODOTHYRONINE;DS-2814;L-3,3',5'-triiodothyronine;1ST177969;DB-021795